Literature DB >> 26711513

Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian Women.

Anna Babakhanyan1, Yeung L Tutterrow1, Naveen Bobbili1, Ali Salanti1, Andrew Wey1, Josephine Fogako1, Robert J Leke1, Rose G F Leke1, Diane Wallace Taylor2.   

Abstract

Intermittent preventive treatment (IPT) and insecticide-treated bed nets are the standard of care for preventing malaria in pregnant women. Since these preventive measures reduce exposure to malaria, their influence on the antibody (Ab) response to the parasite antigen VAR2CSA was evaluated in pregnant Cameroonian women exposed to holoendemic malaria. Ab levels to full-length VAR2CSA (FV2), variants of the six Duffy binding like (DBL) domains, and proportion of high avidity Ab to FV2 were measured longitudinally in 92 women before and 147 women after IPT. As predicted, reduced exposure interfered with acquisition of Ab in primigravidae, with 71% primigravidae being seronegative to FV2 at delivery. Use of IPT for > 13 weeks by multigravidae resulted in 26% of women being seronegative at delivery and a significant reduction in Ab levels to FV2, DBL5, DBL6, proportion of high avidity Ab to FV2, and number of variants recognized. Thus, in women using IPT important immune responses were not acquired by primigravidae and reduced in a portion of multigravidae, especially women with one to two previous pregnancies. Longitudinal data from individual multigravidae on IPT suggest that lower Ab levels most likely resulted from lack of boosting of the VAR2CSA response and not from a short-lived Ab response. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26711513      PMCID: PMC4775902          DOI: 10.4269/ajtmh.15-0521

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  41 in total

Review 1.  An analysis of anemia and child mortality.

Authors:  B J Brabin; Z Premji; F Verhoeff
Journal:  J Nutr       Date:  2001-02       Impact factor: 4.798

2.  An analysis of malaria in pregnancy in Africa.

Authors:  B J Brabin
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

Review 3.  Epidemiology, malaria and pregnancy.

Authors:  I A McGregor
Journal:  Am J Trop Med Hyg       Date:  1984-07       Impact factor: 2.345

4.  Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy.

Authors:  I O'Neil-Dunne; R N Achur; S T Agbor-Enoh; M Valiyaveettil; R S Naik; C F Ockenhouse; A Zhou; R Megnekou; R Leke; D W Taylor; D C Gowda
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bissau.

Authors:  G Snounou; L Pinheiro; A Gonçalves; L Fonseca; F Dias; K N Brown; V E do Rosario
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Nov-Dec       Impact factor: 2.184

6.  Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.

Authors:  Trine Staalsoe; Caroline E Shulman; Edgar K Dorman; Ken Kawuondo; Kevin Marsh; Lars Hviid
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns.

Authors:  Patrick E Duffy; Michal Fried
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes.

Authors:  Stephen J Rogerson; Elena Pollina; Abera Getachew; Eyob Tadesse; Valentino M Lema; Malcolm E Molyneux
Journal:  Am J Trop Med Hyg       Date:  2003-01       Impact factor: 2.345

9.  Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.

Authors:  Trine Staalsoe; Caroline E Shulman; Judith N Bulmer; Ken Kawuondo; Kevin Marsh; Lars Hviid
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

10.  Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission.

Authors:  Andrew Teo; Wina Hasang; Louise M Randall; Holger W Unger; Peter M Siba; Ivo Mueller; Graham V Brown; Stephen J Rogerson
Journal:  Malar J       Date:  2015-05-26       Impact factor: 2.979

View more
  4 in total

Review 1.  Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity.

Authors:  Pamela M Odorizzi; Margaret E Feeney
Journal:  Trends Mol Med       Date:  2016-09-07       Impact factor: 11.951

2.  Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.

Authors:  Barriere A Y Fodjo; Njika Atemnkeng; Livo Esemu; Emile K Yuosembom; Isabella A Quakyi; Viviane H M Tchinda; Joseph Smith; Ali Salanti; Jude Bigoga; Diane W Taylor; Rose G F Leke; Anna Babakhanyan
Journal:  Malar J       Date:  2016-11-04       Impact factor: 2.979

3.  Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens.

Authors:  Ana Maria Fonseca; Llorenç Quinto; Alfons Jiménez; Raquel González; Azucena Bardají; Sonia Maculuve; Carlota Dobaño; Maria Rupérez; Anifa Vala; John J Aponte; Esperanza Sevene; Eusebio Macete; Clara Menéndez; Alfredo Mayor
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

4.  Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women.

Authors:  Andrew Teo; Louise M Randall; Mwayiwawo Madanitsa; Victor Mwapasa; Linda Kalilani Phiri; Carole Khairallah; Christelle Buffet; Amalia Karahalios; David L Narum; Feiko O Ter Kuile; Stephen J Rogerson
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.